semaglutide aspiration during anesthesia case report 2023 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Risk of SciELO Brasil - Risk of
Description
They can present with arrhythmias, angina, heart failure symptoms, or pericardial effusion
Risk is further amplified when comorbidities such as chronic kidney disease coexist, particularly in people with T2DM [14]
The primary safety concern is cumulative hypoglycaemia risk when combined with sulphonylureas or insulin, which may require dose adjustments
**For any medical procedures, patients may respond to treatment differently, each patients results may vary
Next-Step Option for Semaglutide Non-Responders Retatrutide offers a clear escalation path for patients who have not achieved adequate results on existing GLP-1 therapies
So, if you are switching from Mounjaro to Wegovy injections and stop taking Mounjaro with our service, youll start Wegovy after a one-week break
